Radiosurgery for atypical and anaplastic meningiomas: Histopathological predictors of local tumor control

Stereotactic and Functional Neurosurgery

Volumn 90, Issue 5, 2012, Pages 316-324

  Kim, Jin Wook ^a   Kim, Dong Gyu ^a   Paek, Sun Ha ^a   Chung, Hyun Tai ^a   Myung, Jae Kyung ^b   Park, Sung Hye ^b   Kim, Yong Hwy ^a   Han, Jung Ho ^a   Yang, Seung Yeob ^c   Park, Chul Kee ^a   Jung, Hee Won ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Anaplastic meningioma; Atypical meningioma; Local tumor control; Prognostic factor; Radiosurgery

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAPLASTIC MENINGIOMA; ARTICLE; ATYPICAL MENINGIOMA; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ARTICLE; FEMALE; GAMMA KNIFE RADIOSURGERY; HISTOPATHOLOGY; HUMAN; MALE; MENINGIOMA; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; RADIATION DOSE; RADIATION INJURY; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOSURGERY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863764788     PISSN: 10116125     EISSN: 14230372     Source Type: Journal    
DOI: 10.1159/000338253     Document Type: Article

References (27)

1. Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J: Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys 2005; 61: 809-816.
2. Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S, Krengli M, Weber DC, Baumert BG, Canyilmaz E, Yalman D, Szutowicz E, Tzuk-Shina T, Mirimanoff RO: Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the rare cancer network. Int J Radiat Oncol Biol Phys 2008; 71: 1388-1393.
3. Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH: Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 2000; 46: 57-61.
4. Katz TS, Amdur RJ, Yachnis AT, Mendenhall WM, Morris CG: Pushing the limits of radiotherapy for atypical and malignant meningioma. Am J Clin Oncol 2005; 28: 70-74.
5. Mattozo CA, De Salles AA, Klement IA, Gorgulho A, McArthur D, Ford JM, Agazaryan N, Kelly DF, Selch MT: Stereotactic radiation treatment for recurrent nonbenign meningiomas. J Neurosurg 2007; 106: 846-854.
6. Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ: Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 1996; 34: 817-822.
7. Modha A, Gutin PH: Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 2005; 57: 538-550.
8. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC: 'Malignancy' in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85: 2046-2056.
9. Rogers L, Gilbert M, Vogelbaum MA: Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol 2010; 99: 393-405.
10. Vranic A, Popovic M, Cor A, Prestor B, Pizem J: Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients. Neurosurgery 2010; 67: 1124-1132.
11. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
12. Kano H, Takahashi JA, Katsuki T, Araki N, Oya N, Hiraoka M, Hashimoto N: Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 2007; 84: 41-47.
13. Ojemann SG, Sneed PK, Larson DA, Gutin PH, Berger MS, Verhey L, Smith V, Petti P, Wara W, Park E, McDermott MW: Radiosurgery for malignant meningioma: results in patients. J Neurosurg 2000; 93(suppl 3):62-67.
14. Harris AE, Lee JY, Omalu B, Flickinger JC, Kondziolka D, Lunsford LD: The effect of radiosurgery during management of aggressive meningiomas. Surg Neurol 2003; 60: 298-305.
15. Huffmann BC, Reinacher PC, Gilsbach JM: Gamma knife surgery for atypical meningiomas. J Neurosurg 2005; 102(suppl):283-286.
16. Stafford SL, Pollock BE, Foote RL, Link MJ, Gorman DA, Schomberg PJ, Leavitt JA: Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001; 49: 1029-1037.
17. Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A: Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 2007; 27: 114-120.
18. Ho DM, Hsu CY, Ting LT, Chiang H: Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 2002; 94: 1538-1547.
19. Nakaya K, Chernov M, Kasuya H, Izawa M, Hayashi M, Kato K, Kubo O, Muragaki Y, Iseki H, Hori T, Okada Y, Takakura K: Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index. Minim Invasive Neurosurg 2009; 52: 216-221.
20. Takahashi JA, Ueba T, Hashimoto N, Nakashima Y, Katsuki N: The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomas. Surg Neurol 2004; 61: 149-155.
21. Vankalakunti M, Vasishta RK, Das Radotra B, Khosla VK: MIB-1 immunolabeling: A valuable marker in prediction of benign recurring meningiomas. Neuropathology 2007; 27: 407-412.
22. Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW: Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 2008; 79: 574-580.
23. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J: WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 2009; 95: 367-375.
24. Prayson RA: The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms. Adv Anat Pathol 2005; 12: 144-148.
25. Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, Bussiere MR, Ojemann R: Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 2000; 48: 151-160.
26. Kim JW, Kim DG, Chung HT, Paek SH, Kim YH, Han JH, Park CK, Kim CY, Jung HW: Gamma knife stereotactic radiosurgery for intracranial hemangiopericytomas. J Neurooncol 2010; 99: 115-122.
27. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000; 47: 291-298.